126 related articles for article (PubMed ID: 9699788)
1. Repeated dosing with the peroxisome proliferator clofibrate decreases the toxicity of model hepatotoxic agents in male mice.
Manautou JE; Silva VM; Hennig GE; Whiteley HE
Toxicology; 1998 May; 127(1-3):1-10. PubMed ID: 9699788
[TBL] [Abstract][Full Text] [Related]
2. Peroxisome proliferator-activated receptor alpha-null mice lack resistance to acetaminophen hepatotoxicity following clofibrate exposure.
Chen C; Hennig GE; Whiteley HE; Corton JC; Manautou JE
Toxicol Sci; 2000 Oct; 57(2):338-44. PubMed ID: 11006363
[TBL] [Abstract][Full Text] [Related]
3. Protection against acetaminophen hepatotoxicity by a single dose of clofibrate: effects on selective protein arylation and glutathione depletion.
Manautou JE; Emeigh Hart SG; Khairallah EA; Cohen SD
Fundam Appl Toxicol; 1996 Feb; 29(2):229-37. PubMed ID: 8742320
[TBL] [Abstract][Full Text] [Related]
4. The PPAR activator docosahexaenoic acid prevents acetaminophen hepatotoxicity in male CD-1 mice.
Nguyen KA; Carbone JM; Silva VM; Chen C; Hennig GE; Whiteley HE; Manautou JE
J Toxicol Environ Health A; 1999 Oct; 58(3):171-86. PubMed ID: 10522648
[TBL] [Abstract][Full Text] [Related]
5. Clofibrate pretreatment diminishes acetaminophen's selective covalent binding and hepatotoxicity.
Manautou JE; Hoivik DJ; Tveit A; Hart SG; Khairallah EA; Cohen SD
Toxicol Appl Pharmacol; 1994 Dec; 129(2):252-63. PubMed ID: 7992315
[TBL] [Abstract][Full Text] [Related]
6. Protection against acetaminophen hepatotoxicity by clofibrate pretreatment: role of catalase induction.
Chen C; Hennig GE; Whiteley HE; Manautou JE
J Biochem Mol Toxicol; 2002; 16(5):227-34. PubMed ID: 12439864
[TBL] [Abstract][Full Text] [Related]
7. Protection by clofibrate against acetaminophen hepatotoxicity in male CD-1 mice is associated with an early increase in biliary concentration of acetaminophen-glutathione adducts.
Manautou JE; Tveit A; Hoivik DJ; Khairallah EA; Cohen SD
Toxicol Appl Pharmacol; 1996 Sep; 140(1):30-8. PubMed ID: 8806867
[TBL] [Abstract][Full Text] [Related]
8. Differential gene expression in mouse liver associated with the hepatoprotective effect of clofibrate.
Moffit JS; Koza-Taylor PH; Holland RD; Thibodeau MS; Beger RD; Lawton MP; Manautou JE
Toxicol Appl Pharmacol; 2007 Jul; 222(2):169-79. PubMed ID: 17585979
[TBL] [Abstract][Full Text] [Related]
9. Ribose cysteine protects against acetaminophen-induced hepatic and renal toxicity.
Lucas AM; Hennig G; Dominick PK; Whiteley HE; Roberts JC; Cohen SD
Toxicol Pathol; 2000; 28(5):697-704. PubMed ID: 11026606
[TBL] [Abstract][Full Text] [Related]
10. Role of NAD(P)H:quinone oxidoreductase 1 in clofibrate-mediated hepatoprotection from acetaminophen.
Moffit JS; Aleksunes LM; Kardas MJ; Slitt AL; Klaassen CD; Manautou JE
Toxicology; 2007 Feb; 230(2-3):197-206. PubMed ID: 17188792
[TBL] [Abstract][Full Text] [Related]
11. Effects of clofibrate and indocyanine green on the hepatobiliary disposition of acetaminophen and its metabolites in male CD-1 mice.
Chen C; Hennig GE; McCann DJ; Manautou JE
Xenobiotica; 2000 Nov; 30(11):1019-32. PubMed ID: 11197064
[TBL] [Abstract][Full Text] [Related]
12. Dose- and route-dependent alterations in metabolism and toxicity of chemical compounds in ethanol-treated rats: difference between highly (chloroform) and poorly (carbon tetrachloride) metabolized hepatotoxic compounds.
Wang PY; Kaneko T; Tsukada H; Nakano M; Sato A
Toxicol Appl Pharmacol; 1997 Jan; 142(1):13-21. PubMed ID: 9007029
[TBL] [Abstract][Full Text] [Related]
13. Acetaminophen nephrotoxicity in the CD-1 mouse. II. Protection by probenecid and AT-125 without diminution of renal covalent binding.
Emeigh Hart SG; Wyand DS; Khairallah EA; Cohen SD
Toxicol Appl Pharmacol; 1996 Jan; 136(1):161-9. PubMed ID: 8560470
[TBL] [Abstract][Full Text] [Related]
14. Gender-related differences in susceptibility to acetaminophen-induced protein arylation and nephrotoxicity in the CD-1 mouse.
Hoivik DJ; Manautou JE; Tveit A; Hart SG; Khairallah EA; Cohen SD
Toxicol Appl Pharmacol; 1995 Feb; 130(2):257-71. PubMed ID: 7871539
[TBL] [Abstract][Full Text] [Related]
15. The effect of an 11.5-hr/day exposure schedule on the distribution and toxicity of inhaled carbon tetrachloride in the rat.
Paustenbach DJ; Christian JE; Carlson GP; Born GS
Fundam Appl Toxicol; 1986 Apr; 6(3):472-83. PubMed ID: 3699332
[TBL] [Abstract][Full Text] [Related]
16. Type 1 diabetic mice are protected from acetaminophen hepatotoxicity.
Shankar K; Vaidya VS; Apte UM; Manautou JE; Ronis MJ; Bucci TJ; Mehendale HM
Toxicol Sci; 2003 Jun; 73(2):220-34. PubMed ID: 12700423
[TBL] [Abstract][Full Text] [Related]
17. The influence of ethanol pretreatment on the effects of nine hepatotoxic agents.
Strubelt O; Obermeier F; Siegers CP
Acta Pharmacol Toxicol (Copenh); 1978 Sep; 43(3):211-8. PubMed ID: 568375
[TBL] [Abstract][Full Text] [Related]
18. Late dimethyl sulfoxide administration provides a protective action against chemically induced injury in both the liver and the kidney.
Lind RC; Gandolfi AJ
Toxicol Appl Pharmacol; 1997 Jan; 142(1):201-7. PubMed ID: 9007050
[TBL] [Abstract][Full Text] [Related]
19. Effect of ribose cysteine pretreatment on hepatic and renal acetaminophen metabolite formation and glutathione depletion.
Slitt AM; Dominick PK; Roberts JC; Cohen SD
Basic Clin Pharmacol Toxicol; 2005 Jun; 96(6):487-94. PubMed ID: 15910414
[TBL] [Abstract][Full Text] [Related]
20. Comparative studies on the hepatotoxic actions of chloroform and related halogenomethanes in normal and phenobarbital-pretreated animals.
Masuda Y; Yano I; Murano T
J Pharmacobiodyn; 1980 Jan; 3(1):53-64. PubMed ID: 6259312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
